Table 41 (Abstract P294). Subgroup analysis
From: 36th International Symposium on Intensive Care and Emergency Medicine
Subgroup analysis | Mortality | Infections |
|---|---|---|
Monotherapy | RR 0.91 (95% CI 0.80, 1.04; P = 0.18) | RR 0.95 (95% CI 0.85, 1.06; P = 0.36) |
Combined therapy | RR 1.08 (95% CI 0.93, 1.25; P = 0.33) | RR 0.90 (95% CI 0.78, 1.05; P = 0.18) |
High dose | RR 0.98 (95% CI 0.87, 1.11; P = 0.78) | RR 0.97 (95% CI 0.89, 1.05; P = 0.46) |
Daily dose = 500 mcg | RR 0.88 (95% CI 0.57, 1.34; P = 0.54) | RR 0.87 (95% CI 0.64, 1.19; P = 0.39) |
Low dose | RR 0.94 (95% CI 0.67, 1.33; P = 0.75) | RR 0.87 (95% CI 0.72, 1.05; P = 0.15) |
Loading dose | RR 0.91 (95% CI 0.76, 1.09; P = 0.30) | RR 0.99 (95% CI 0.90, 1.09; P = 0.84) |
No loading dose | RR 1.01 (95% CI 0.90, 1.14; P = 0.83) | RR 0.87 (95% CI 0.77, 0.99; P = 0.03) |